All the more reason not to belittle BOT, the success of BTX1801 could do amazing things for the entire medcan sector.
If BOT succeeds, then it enhances the legitimacy of medcan, which in turn increases IHL’s public profile and allows Sud to sell to and raise cash from institutions who by nature are extremely conservative.
Play the long game, play to our strengths and IHL will be HUGE winners.
IHL Price at posting:
6.1¢ Sentiment: Buy Disclosure: Held